Humacyte Inc (HUMA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HUMA? Forum Prognose

Finanzdaten der Humacyte Inc-Aktie (HUMA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	150.17% 0.753	0.301	0.517	-	-
Cost Of Revenue	22.07% 0.26	0.213	0.147	-	-
Gross Profit	460.23% 0.493	0.088	0.37	-	-
Operating Expenses	16.54% 24.88	29.82	23.55	28.09	30.23
Benefits Costs and Expenses	16.27% 25.14	30.03	23.70	-	-
Costs And Expenses	16.27% 25.14	30.03	23.70	-	-
Operating Income/Loss	17.95% -24.39	-29.73	-23.18	-28.09	-30.23
Nonoperating Income/Loss	186.75% 6.88	-7.931	62.32	7.148	-8.969
Income/Loss From Continuing Operations Before Tax	35.23% -24.39	-37.66	39.14	-20.94	-39.20
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	53.50% -17.51	-37.66	39.14	-20.94	-39.20
Net Income/Loss	53.50% -17.51	-37.66	39.14	-20.94	-39.20
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.85% 158.31	155.44	131.50	2.8555	119.41
Diluted Average Shares	1.85% 158.31	155.44	131.76	2.8555	119.41
Basic Earnings Per Share	54.17% -0.11	-0.24	0.28	-0.16	-0.33
Diluted Earnings Per Share	54.17% -0.11	-0.24	0.28	-0.16	-0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%